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Abstract
Background: Breech presentation occurs in 3 to 4% of all term pregnancies. External cephalic version (ECV) is proven 
effective to prevent vaginal breech deliveries and therefore it is recommended by clinical guidelines of the Royal Dutch 
Organisation for Midwives (KNOV) and the Dutch Society for Obstetrics and Gynaecology (NVOG). Implementation of 
ECV does not exceed 50 to 60% and probably less.
We aim to improve the implementation of ECV to decrease maternal and neonatal morbidity and mortality due to
breech presentations. This will be done by defining barriers and facilitators of implementation of ECV in the
Netherlands. An innovative implementation strategy will be developed based on improved patient counselling and
thorough instructions of health care providers for counselling.
Method/design: The ultimate purpose of this implementation study is to improve counselling of pregnant women 
and information of clinicians to realize a better implementation of ECV.
The first phase of the project is to detect the barriers and facilitators of ECV. The next step is to develop an
implementation strategy to inform and counsel pregnant women with a breech presentation, and to inform and
educate care providers. In the third phase, the effectiveness of the developed implementation strategy will be
evaluated in a randomised trial. The study population is a random selection of midwives and gynaecologists from 60
to 100 hospitals and practices. Primary endpoints are number of counselled women. Secondary endpoints are
process indicators, the amount of fetes in cephalic presentation at birth, complications due to ECV, the number of
caesarean sections and perinatal condition of mother and child. Cost effectiveness of the implementation strategy
will be measured.
Discussion: This study will provide evidence for the cost effectiveness of a structural implementation of external 
cephalic versions to reduce the number of breech presentations at term.
Trial Registration: Dutch Trial Register (NTR): 1878
Background
Breech presentation occurs in 3 to 4% of all term preg-
nancies [1]. In pregnancies complicated by breech pre-
sentation, perinatal mortality, neonatal mortality or
serious neonatal morbidity are increased as compared to
pregnancies where the fetes is in cephalic position [2].
Breech position at term occurs in 8.000 pregnancies in
the Netherlands each year. Until 2000 the mode of breech
delivery was controversial. Since publication of the
results of the term breech trial, the caesarean delivery
rate in women with a fetes in breech presentation in the
Netherlands has increased from 45% to around 80% [3].
Although an elective caesarean section is safer for the
baby, it increases maternal morbidity [4]. Moreover, the
uterine scar carries a risk for future pregnancies [5].
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cephalic presentations at term with 40-50%, and thus the
number of caesarean deliveries performed for at term
breech presentation, without any increased risk to the
baby [6]. The high caesarean delivery rate for breech pre-
sentation makes ECV an important obstetric intervention
and it is therefore recommended by the Royal College of
Obstetricians and Gynaecologists in the Clinical Green
Top Guidelines.
A recent inventory among Dutch gynaecologists
showed that 5% of the practices never offered ECV,
whereas one practice offered ECV only to multipara. In
28% of the practices an ECV was performed by all
gynaecologists, whereas in the other 72% ECV was per-
formed by a smaller team of specialists. The palette of rel-
ative contraindications differed widely, and only 19% of
the responding clinics registered their success rates. The
number of patients refusing ECV was estimated to be 20
to 30%. At present, 60 to 70% of the women with a fetes in
breech position undergoes ECV in the Netherlands. This
rate is probably an overestimation, as they are based on
self reported rates by midwives and gynaecologists, in the
absence of registrations. The true number of women that
undergoes ECV for term breech is probably below 50%.
With 6.000 term breech deliveries each year, of which
5.000 are delivered by caesarean section, there is clearly
room for improvement. The number of caesarean sec-
tions for breech delivery can de reduced with approxi-
mately 2.000 per year. As the additional costs of a
caesarean section as compared to vaginal delivery are
estimated to be 1.500 Euros, the potential saving of a bet-
ter implementation of ECV can reduce costs with 2 to 3
million Euros per year for direct medical costs only. As
pregnant women with a previous caesarean section are at
increased risk of complications, and therefore always
deliver under responsibility of a gynaecologist, the poten-
tial savings are even higher.
In the Netherlands, there is professional consensus
among the Dutch Society for Obstetrics and Gynaecology
(NVOG) as well as the Royal Dutch Organisation for
Midwives (KNOV) that ECV should be offered to all
women with a fetes in breech presentation at term. The
KNOV has produced a leaflet for patients in which ECV
is recommended. Nevertheless, the number of women
potential suitable for ECV who were not offered an
attempt range from 4% to 33% [7-9]. Moreover, a substan-
tial number of women refuse ECV, and opt immediately
for a caesarean section. In Australia, Raynes-Greenow
and others investigated pregnant women's preferences
and knowledge of term breech management [10]. 39%
would choose ECV, 39% would not choose ECV, and the
remaining 22% were uncertain. Yogev and colleagues per-
formed a similar study in Israel [11]. They reported that
in 1995, more than half the women (52.7%) had heard of
ECV and 53.8% were willing to consider it, whereas in
2001, 73.2% had heard of it but only 23.9% were willing to
consider it. Johanson reported that out of a group of 323
pregnant women with a fetes in breech presentation, 65%
opted for external cephalic version after they were
informed [12]. They also demonstrated an association
between the gynaecologists who provided information
and the level of uptake by the women.
The number of women with a breech presentation con-
sidering ECV and their knowledge about the procedure
are unknown in the Netherlands. Until publication of the
new NVOG and KNOV guidelines in 2001 and 2002,
ECV used to be a controversial intervention. Since the
introduction of these guidelines, there is no evidence for
a raise in the number of ECVs performed. However, the
number of birth in breech presentation at term is stable
since 2002, indicating a low implementation grade of
ECV.
Implementation requires a clear and deliverable evi-
dence based message [13]. However, there are often
major discrepancies between best evidence and practice,
resulting in a large variation between professionals [14-
17]. Based on this national and international literature,
two main barriers for ECV implementation are identified
1) lack of patients' knowledge about risk for and conse-
quences of ECV and breech delivery 2) the attitude and
knowledge of midwives and gynaecologists towards ECV.
This study will show us if an implementation strategy,
tailored on main barriers combining both patient and
health care provider interventions, is more cost-effective
than usual care. We will also evaluate the process of
implementation to ascertain which elements of the strat-
egy can be particularly associated with successful imple-
mentation of ECV. Moreover, our proposal is a
collaborative effort of midwives and gynaecologists, and
is supported by both the KNOV and NVOG.
Methods/Design
Aims
The main objective of this study is to assess barriers and
facilitators of implementation of ECV in the Netherlands.
We would like to create a broad social basis and aware-
ness for the need of cooperation in care for women with a
fetes in breech position. An innovative implementation
strategy will be developed based on improved patient
counselling and thorough instructions of health care pro-
viders for counselling.
Research questions are: What are barriers and facilita-
tors of implementation of ECV in the Netherlands? What
are the costs and effects of an innovative implementation
strategy based on improved patient counselling and infor-
mation of health care providers to implement the guide-
lines on ECV for breech presentation? What is the
feasibility of this implementation strategy?
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The proposal will contain three phases. In the first phase,
we will identify facilitators and barriers of implementa-
tion of ECV and create awareness of the need for
improvement. Subsequently, we will develop an imple-
mentation strategy targeted on patient counselling and
information of health care providers, and evaluate the
cost-effectiveness of the developed strategy.
Identification of facilitators and barriers of implementation 
of ECV
A topic list will be defined by an expert panel. The topic
list will be constructed on the basis of existing knowledge
and theories on implementation factors, primarily based
on the clinical guidelines by the NVOG and KNOV. This
list will be used to guide and direct semi-structured inter-
views and focus groups, patients, gynaecologists and
midwives will be asked for their attitude towards ECV.
We will assess fear for complications, skills and attitudes.
A framework approach will be used to analyse the data
and to derive potential factors that might influence the
implementation of ECV [18].
In the second step the exploratory findings will be used
to develop a series of questionnaires. These will then be
distributed among a much larger number of actors.
Quantitative analyses will be conducted, accounting for
the multilevel nature of the problem and the correspond-
ing data-collection, to study the prevalence of factors that
facilitate and/or inhibit the implementation of external
cephalic version in the Netherlands. In this process, we
will take into account regional and socio-economic dif-
ferences. To identify and explore relevant factors, semi-
structured interviews will be held with pregnant women
with a fetes in breech presentation (N = 20), general prac-
titioners (N = 20), midwives (N = 20), gynaecologists (N =
20), and representatives of health care insurers. Respon-
dents will be 'purposively' selected [19]. Gynaecologists
and midwives will be selected on relevant characteristics
of their practices (region, hospital). Moreover, we will
interview partners of pregnant women separately, but
also as a couple. The interviews will be guided by the
topic list that is defined on the basis of existing knowl-
edge and theories on implementation [20]. The topic list
will be used to direct the interviews, but will be infor-
mally and flexible applied in order to prevent us from
imposing our preconceptions. The topic list will contain
themes that include knowledge of the complications of
ECV, about the risks of caesarean section in terms of
short- and long term maternal and neonatal mortality
and morbidity, and about available evidence. We will ask
couples about their attitude towards the problem, about
their expectations and previous experiences, and about
their beliefs about health care in general. Midwives and
gynaecologists will be interviewed on similar subjects,
but they will be asked more extensively about the poten-
tial effectiveness of ECV (relative risks, numbers needed
to treat, numbers needed to harm) as well as the influ-
ence of wider societal, organisational, financial, and con-
textual factors. We expect the following categories of
factors to play a role: socio-political factors (opinion
stated by opinion leaders, comments in journals, opinion
of experts within the own department, attitude of the
head of the department), organizational factors, and
knowledge and beliefs (doctor and patient level, (the lack
of) knowledge, about complications of vaginal breech
delivery and caesarean section, anxiety for ECV and the
demand for caesarean section (patient level only)). The
semi-structured interviews will be analyzed on the basis
of a framework approach [18]. The analyses will help us
identify the important factors that are most likely to play
a role in the implementation of ECV. We expect that we
will be able to distil a list of approximately fifteen issues
that are of potential importance. The exploratory findings
will be used to develop a questionnaire, which is sup-
posed to be extensive and complete. The questionnaire
will be sent to all midwives practices and to the depart-
ments of obstetrics and gynaecology of all hospitals in the
Netherlands. Moreover, all health insures will be tar-
geted.
Ethical approval is not needed in accordance to the pre-
scriptions of the medical ethical committee of the AMC,
if individual patients will be approached for semi struc-
tured interviews, without provocation of emotional
arousal and with anonymous processing of the data study.
Development of an implementation plan
After analysis, the results will be discussed in a final
meeting with the study group and representative partici-
pants (clients, midwives, gynaecologists). Based on the
discussion of these results, an implementation plan, with
different actions and interventions, will be developed.
Although parts of the plan will highly depend on the
obstacles of change to be identified (e.g. knowledge, atti-
tude, behaviour, logistics), we anticipate the following
ingredients: 1) an educational brochure/website with evi-
dence, one designed for gynaecologists/midwives and
one designed for patients. 2) group/unit meetings to dis-
cuss the protocol, the resistance to it, and how to over-
come problems in adaptation. 3) if necessary, a training in
counselling patients on ECV for midwifes and/or
gynaecologists can be developed 4) reminders; regular
self monitoring; regular observation by heads of units.
This plan will be developed according to phase 2 to 5 of
Grols 5-step implementation model. Depending on the
results of the proposed project, additional funding will be
sought for these phases.
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design
A cluster randomised controlled trial with an economic
evaluation will be performed alongside. Ethical approval
will be requested before the start of this part of the study.
Information on counselling of patients, required for ethi-
cal approval, will be specified in the first phase of the
trial. A set of quality indicators will be extracted from the
NVOG and KNOV guidelines. The indicator develop-
ment will be performed according to the RAND-modi-
fied Delphi method [21]. First of all, key
recommendations from the guidelines will be extracted
by two or three experts, the project leaders. Subsequently,
the clinical relevance of all key recommendations for
patient's health benefit and efficacy will be tested in two
rounds among an independent panel of 12-15 experts
(KNOV and NVOG guideline writers, KNOV and
NVOG members, quality of care experts and patients).
The key recommendations with the highest scores will be
selected and made ready for use, in measurable elements
(process indicators). Moreover, measurement instru-
ments will be developed and the participating hospitals
will be informed about the study. A detailed protocol on
the randomised controlled trial will be written after fin-
ishing the first phase.
This is a requirement to receive further funding of the
further project. This protocol is in development; it
depends mainly in the outcome of the first phase. This
will be followed by a pilot, feasibility study where two dif-
ferent implementation strategies will be tested in four
participating hospitals, one primary care centre special-
ised in ECV and one independent midwifery practice.
Before the pilot study starts, baseline characteristics and
primary and secondary outcomes will be measured with
questionnaires and data gathering on amount of version
attempts, outcomes after ECV and caesarean section rate.
The data gathering lists and questionnaires will also be
developed during the first phase.
After the pilot study a cluster randomised controlled
trial will be performed in which two implementation
strategies will be evaluated: a patient centred strategy and
a health care provider (midwife and gynaecologist) cen-
tred strategy. In the randomised clinical trial, we will allo-
cate centres and their regions at random to four groups:
A. Patient centred strategy alone, B. Healthcare provid-
ers-centred strategy alone, C. Both the patient and
healthcare provider centred strategies, D. No specific
implementation intervention.
Up to 30% of eligible patients are not offered an ECV
attempt and up to 40% of counselled patients do not
choose for ECV, which might be the result of insufficient
information. With the decision aid we intend to increase
the number of well informed patients from 50 to 80%. To
correct for the degree of similarity among responses
within a cluster, a intra-cluster correlation coefficient of
0.10 was integrated in the power analyses. To be able to
show the difference of 30% with a power of 80% and an
alpha error of 5%, we need 20 clusters of a 30 patients
each. The gynaecologists in the participating hospitals
will give informed consent for this trial to confirm that
they will treat their patients conform one of the four
strategies were they will be allocated to, as long as the
trial is open for inclusion.
Outcome measures and process indicators
Primary endpoint is the number of patients that has an
ECV performed. Secondary endpoints are guidelines'
adherence rates, complications of ECV, the number of
fetes that are in cephalic position at delivery, the number
of caesarean sections and the perinatal condition of
mother and child. Moreover, we will assess patients'
knowledge (e.g. ECV, breech delivery, caesarean section),
patients' decisional conflict and patients' satisfaction. We
will also calculate costs of both implementation interven-
tions and medical interventions. In case one or both
implementation interventions are effective, their cost-
effectiveness will be assessed.
Implementation study
An effect and process evaluation will be performed. An
effect evaluation of the two strategies will be carried out
using the primary and secondary outcome measures and
the set of process indicators derived from the NVOG and
KNOV guidelines. This will be done among pregnant
women with breech presentation at term and profession-
als involved in the care for these women. The measure-
ments will be performed in the 20 participating hospitals
before and after implementation of the different strate-
gies by a medical record search, added with question-
naires among professionals and patients. The medical
records will be searched using standardised registration
forms. A process evaluation will be performed to study
the feasibility of the two strategies. The extent by which
clinicians, midwives and patients used these elements will
be measured.
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